AM-Pharma closes €12.2m financing round

by Ysios Capital

​AM‐Pharma B.V., a biopharmaceutical company focused on the development of recAP (recombinant human Alkaline Phosphatase) for inflammatory indications, announces that it has closed a €12.2 milli...

Read more
Subscribe to Directory
Write an Article

Highlight

Axon moves into Cloud Technology

by Axon Partners Group

cloud technology axon

Baker Tilly advises Business Software Gr...

by Baker Tilly

In February 2024, Business Software Group (BSG) launched a initial pub...

Photos Stream